Lipidor
0,188
SEK
+3,87 %
LIPI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 investorer følger denne virksomhed
+3,87%
+60,68%
+42,42%
+31,01%
+42,19%
+58,54%
-91,42%
-94,14%
-89,37%
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Læs mereMarkedsværdi
152,92 mio. SEK
Aktieomsætning
842,11 t SEK
Omsætning
80 t
EBIT %
-19.312,5 %
P/E
-
Udbytteafkast, %
-
Finanskalender
28.2
2025
Årsrapport '24
3.6
2025
Generalforsamling '24
28.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025"
Lipidor announces first patient enrolled in Phase III study of AKP02G2 for topical treatment of psoriasis
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools